Sutro Biopharma Inc (STRO) Stock Message Board | InvestorsHub

Jan 1, 2025 · STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) …

$5.00
OFF

Sutro Biopharma Inc (STRO) Stock Message Board | InvestorsHub

2 weeks from now

Jan 1, 2025 · STRO: I launched this new iHub board today due to the below-pasted reply I got from GOOGLE's (AI) search routine regarding my following question: "Which (under $5.00) …

advfn.com

$11.13
OFF

Sutro Biopharma (STRO) Stock Forecast And Price Target 2025

2 weeks from now

1 day ago · Learn why top analysts are making this stock forecast for Sutro Biopharma at MarketBeat. STRO's current price target is $11.13. Learn why top analysts are making this …

marketbeat.com

FAQs about Sutro Biopharma Inc (STRO) Stock Message Board | InvestorsHub Coupon?

What happened to Sutro Biopharma (Stro) stock?

The price of STRO shares has decreased $0.02 since the market last closed. This is a 0.88% drop. Opened at $2.98. The stock opened $0.14 higher than its previous close. Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. ...

How did Sutro Biopharma's stock perform in 2025?

Sutro Biopharma's stock was trading at $1.84 at the beginning of 2025. Since then, STRO stock has increased by 10.9% and is now trading at $2.04. How were Sutro Biopharma's earnings last quarter? Sutro Biopharma, Inc. (NASDAQ:STRO) posted its quarterly earnings data on Tuesday, August, 13th. ...

Where can I buy Sutro Biopharma stock?

Shares of STRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sutro Biopharma own? ...

How did Sutro Biopharma (Stro) perform in the quarter?

Sutro Biopharma, Inc. (NASDAQ:STRO) posted its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.59) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.79) by $0.20. The firm had revenue of $25.71 million for the quarter, compared to analyst estimates of $26.28 million. ...

How many shares of Sutro Biopharma have been sold short?

2.98% of the outstanding shares of Sutro Biopharma have been sold short. Sutro Biopharma has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume. ...

Will Sutro Biopharma (Stro) gain 9% in a week?

Sutro Biopharma (STRO) gains 9% in a week after initiating a phase II study on its lead candidate, luvelta, to treat FRa-expressing lung cancer. Initial data from the trial are anticipated in the first half of next year. ...